Participated in EURO-CAS (2016-2018), which developed the EU eHealth Interoperability Conformity Assessment Scheme.
ARSENAL.IT - CENTRO VENETO RICERCAE INNOVAZIONE PER LA SANITA DIGITALE
Italian eHealth research centre with expertise in digital health interoperability standards and pan-European paediatric clinical trial networks.
Their core work
Arsenal.IT is the Veneto region's dedicated research centre for digital health innovation, headquartered in Treviso, Italy. Their work sits at the intersection of eHealth technology, clinical data infrastructure, and regulatory standards — they help healthcare systems speak the same digital language and support the design of clinical research networks. In the EURO-CAS project they contributed to defining EU-wide conformity assessment schemes for eHealth interoperability, and in the c4c network they support pan-European infrastructure for running clinical trials in children and adolescents. They function as a regional bridge between Italian healthcare IT capabilities and broader European clinical research coordination.
What they specialise in
Active participant in c4c (2018-2025), a large RIA consortium building pan-European clinical trial infrastructure specifically for children, adolescents, and neonates.
Keywords from c4c include data, platform, and infrastructure, indicating involvement in clinical data systems supporting drug development in paediatric populations.
c4c keywords include education, expert advice, and best practice, suggesting Arsenal.IT contributes to training and knowledge-sharing components within clinical networks.
How they've shifted over time
Arsenal.IT entered H2020 through a digital health standards project (EURO-CAS, 2016-2018), focused on technical interoperability and conformity assessment schemes — work that is closer to health IT governance than clinical science. Their second project, c4c (2018-2025), represents a clear shift toward clinical research infrastructure: the keyword set is dominated by clinical trial, drug development, children, neonates, and expert advice, signalling a move into regulated clinical environments rather than IT standards. The trajectory suggests the organisation is growing from eHealth digitisation expert into a clinical research support and coordination role, particularly for vulnerable patient populations.
Arsenal.IT is moving from digital health standardisation into clinical research network support, with a specific emerging niche around paediatric and neonatal medicine — a regulated, underserved area with growing EU policy attention.
How they like to work
Arsenal.IT has never led an H2020 project — both participations are as consortium partner, suggesting they contribute specialist capacity rather than drive research agendas. Despite only two projects, they have accumulated 75 unique consortium partners across 22 countries, which means they consistently join large, pan-European networks rather than small bilateral collaborations. This makes them an accessible, non-competing partner for consortia that need regional Italian eHealth or clinical research expertise without a heavyweight lead institution dynamic.
Across just two projects, Arsenal.IT has connected with 75 distinct consortium partners in 22 countries — an unusually wide footprint for such a small portfolio, reflecting their participation in large, multi-partner European networks like c4c. No strong geographic concentration is evident beyond their Italian base.
What sets them apart
Arsenal.IT occupies a rare dual position: a regional Italian research centre with credibility in both eHealth technical standards and paediatric clinical research networks — two domains that rarely overlap. For consortium builders, this makes them useful as a bridge between health IT infrastructure and clinical trial methodology, particularly in projects touching regulatory compliance or digital tools for clinical data in children. Their non-coordinating posture also means they are unlikely to compete for leadership, making them a low-friction partner for consortia that already have a lead institution.
Highlights from their portfolio
- c4cThe largest project by far (EUR 212,500, running to 2025), c4c is a flagship EU network for paediatric clinical trials covering children, adolescents, and neonates — a high-impact, policy-relevant area with direct pharmaceutical and regulatory implications.
- EURO-CASArsenal.IT's first H2020 project established their credentials in eHealth interoperability governance at EU level, a foundational capability that distinguishes them from purely clinical research organisations.